Port Capital LLC Novartis Ag Transaction History

Port Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $250,984 - $283,912	-3,133 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $16,356 - $19,028	-200 Reduced 6.0%	3,133 $256,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $75,150 - $88,623	-900 Reduced 21.26%	3,333 $285,000
Q1 2020 May 15, 2020	SELL	$70.67 - $99.01 $7,067 - $9,901	-100 Reduced 2.31%	4,233 $349,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $85,540 - $94,260	-1,000 Reduced 18.75%	4,333 $377,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $143,260 - $176,320	-1,900 Reduced 26.27%	5,333 $487,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $85,412 - $97,694	-1,134 Reduced 13.55%	7,233 $695,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $560,086 - $647,856	8,367 New	8,367 $721,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Port Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Port Capital LLC with notifications on news.